TITLE

Letter: Beta-adrenergic blocking agents in renal failure

AUTHOR(S)
Kincaid-Smith, P; Hua, A S
PUB. DATE
August 1974
SOURCE
British Medical Journal;8/24/1974, Vol. 3 Issue 5929, p520
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64111533

 

Related Articles

  • NEW INDICATIONS.  // Drug Topics;6/2/2003, Vol. 147 Issue 11, p77 

    Reports on the approval of an indication for Coreg, a beta-adrenergic blocking agent from GlaxoSmithKline.

  • beta blocker.  // Taber's Cyclopedic Medical Dictionary;2005, p240 

    A definition of the medical term "beta blocker" is presented, which means a beta-adrenergic blocking agent.

  • Treatment of migraine.  // Nutrition Health Review: The Consumer's Medical Journal;1994, Issue 70, p3 

    Presents several drugs used for treatment of migraine. Analgesics; Ergotamine, sumatriptan and clonidine for severe episodes; Beta-adrenergic blocking agents; Serotonin inhibitors.

  • LETTERS: Consider Hanta virus in cases of renal failure.  // GP: General Practitioner;3/1/2004, p49 

    Presents a letter to the editor on renal failure.

  • Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. McCullough, Peter A.; Haapio, Mikko; Mankad, Sunil; Zamperetti, Nereo; Massie, Barry; Bellomo, Rinaldo; Berl, Tomas; Anker, Stefan D.; Anand, Inder; Aspromonte, Nadia; Bagshaw, Sean M.; Bobek, Ilona; Cruz, Dinna N.; Daliento, Luciano; Davenport, Andrew; Hillege, Hans; House, Andrew A.; Katz, Nevin; Maisel, Alan; Mebazaa, Alexandre // Nephrology Dialysis Transplantation;Jun2010, Vol. 25 Issue 6, p1777 

    The article focuses on the prevention of acute kidney injury (AKI) components of cardio-renal syndromes (CRS). It states that type 1 acute cardio renal failure, which is characterized by an initial abrupt change in cardiovascular function, is prevented through blood pressure control, use of...

  • New beta-blocker aims to mend broken hearts. Portyansky, Elena // Drug Topics;6/16/97, Vol. 141 Issue 12, p27 

    Reports on the drug Coreg (carvedilol), a nonselective beta-adrenergic blocking agent with alpha1-blocking activity that is the first of its kind to be cleared by the US Food and Drug Administration for mild or moderate heart failure of ischemic or cardiomyopathic origin. Promotion by...

  • Recurrent Ventricular Tachycardia and Fibrillation Treated with a Combination of Beta--Adrenergic Blockade and Electrical Pacing.  // Annals of Internal Medicine;May67, Vol. 66 Issue 5, p946 

    Describes the treatment of recurrent paroxysmal ventricular tachycardia and ventricular fibrillation with a combination of a beta-adrenergic blocking agent and electrical pacing in a girl without heart disease. Health benefits of beta-adrenergic blocking drugs; Extensive function of cardiac...

  • Effects of adrenergic nervous system and catecholamines on systemic and renal hemodynamics, sodium and water excretion and renin secretion. Schrier, Robert W. // Kidney International;Jul1974, Vol. 6 Issue 1, p291 

    The article focuses on the effects of adrenergic nervous system and catecholamines on systemic and renal hemodynamics, sodium and water excretion, and renin secretion. Endogenous catecholamines, norepinephrine and epinephrine, each exert a combination of alpha- and beta- adrenergic effects and...

  • Pharmacoeconomics of beta-blockers: effective and cost-effective therapy in chronic heart failure. Krum, Henry; Lim, Stephen // European Journal of Heart Failure;Aug2001, Vol. 3 Issue 4, p399 

    The authors reflect on the economical value of the use of beta-blockers as treatment for chronic heart failure (CHF). The authors mention that CHF has became a primary economic burden of health care system in many countries like the Netherlands and France. They add that beta-adrenergic blocking...

  • Many MI patients don't get beta blockers; those who do are under-dosed.  // Geriatrics;Sep95, Vol. 50 Issue 9, p56 

    Presents an abstract of the paper, `Treatment With Beta-Adrenergic Blocking Agents After Myocardial Infarction: From Randomized Trials to Clinical Practice,' by S. Viskin et al, published in the journal, `Geriatrics,' dated September 1995.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics